retatrutide weight loss clinical trial Retatrutide, Eli Lilly's next generation of injections, showed dramatic results in trials, with patients losing an average of up to 71.2 pounds, or 28.7% of their body weight. Eli Retatrutide for weight loss: Study

The most frequently reported NAEs included dizziness (n = 7,078), tremor (n = 2,519), dysgeusia (n = 1,469), lethargy (n = 783), taste disorder (n = 482), presyncope (n = 370), allodynia (n = 192), and parosmia (n = 192) (Fig

These weight loss treatments slow digestion and can cause side effects, which can delay or reduce absorption of oral medicines including the contraceptive pill

Recent advancements in metabolomics technology have revealed significant changes in microbial metabolites like short-chain fatty acid (SCFAs), tryptophan metabolites, bile acids, and phytoestrogens in MS

A Guide for Caregivers Advance Care Planning for People With Cancer and Their Loved Ones Call

At Vive Ageless Weight Loss Center, the team provides personalized guidance to help patients understand emerging therapies like BPC 157 and how they may relate to wellness, recovery, and long-term health goals

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial